300347-基本财务实时评分详情
泰格医药300347基本财务实时评分详情
更新时间:2021-09-27 00:00:01
股票代码
300347
当期评分
股票名称
泰格医药
报告日期2018-12-312019-12-312020-09-302020-09-302020-09-302020-09-30
每股经营现金流(¥)1.04410.70380.59250.59250.5925
销售净利润率(%)22.028334.791860.986960.986960.9869
销售毛利率(%)42.703446.084848.145248.145248.1452
净资产收益率(%)17.6919.928.248.248.24
营业增长率(%)36.373121.848113.267813.267813.2678
净利润增长率(%)52.570292.4483143.0727143.0727143.0727
每股收益(%)0.9441.131.71391.34440.3402
现金流量比率(%)43.20929.461157.473410.11184.6216
三项费用比重(%)16.345115.705520.922915.851616.2832
每股净资产(¥)5.33535.637618.32546.91936.0306
流动比率(%)1.32651.881913.9121.76051.8195
速动比率(%)1.32611.881313.91031.75991.8182
现金比率(%)58.2875114.05121219.0493103.7097103.7097
总资产利润率(%)12.890816.513510.643912.33243.2879
主营利润比重%162.1029118.614271.675961.9815104.5959
应收账款(万元)78,093.87107,472.2242,155.0241,277.8537,600.41
应收票据(万元)73.42567.02503.33372.76496.73
预付款项(万元)4,715.772,607.964,625.093,511.403,767.96
存货(万元)51.89120.56155.27129.64241.25
在建工程(万元)--2,230.911,342.631,326.472,454.93
应付款项(万元)4,402.757,519.156,140.516,038.856,298.58
长期借款(万元)343.173,650.00--13,610.0013,610.00
未分配利润(万元)101,070.23179,596.43287,420.95255,499.53205,093.37
商誉(万元)103,292.69115,783.09152,523.58135,468.11136,312.36
流动资产(万元)267,654.08416,269.14631,544.98544,281.50474,156.69
流动负债(万元)120,864.22179,069.2389,951.71217,250.13192,394.12
泰格医药300347评分结果
66.67分
买入/增持

copyright@ YOUVERY TECHNOLOGY CO., 厦门优极网络科技有限公司©
闽ICP备17005296号-3
地址:厦门市湖里区高崎道890号 邮编:361006